REGN

Regeneron Pharmaceuticals
HealthcareBiotechnologyMkt Cap: 110BAvg Vol: 800K

ABOUT REGN

Regeneron is a biotechnology company known for Eylea (wet macular degeneration), Dupixent (eczema, asthma), Libtayo (cancer), and Kevzara (rheumatoid arthritis). Co-founded by scientist-CEO Leonard Schleifer and Nobel-adjacent researcher George Yancopoulos, Regeneron is renowned for its deep R&D culture and antibody discovery platform.

WHY TRACK REGN ON SQUAWKFLOW

REGN options flow spikes around Dupixent indication expansions and Eylea biosimilar competition updates. Institutional positioning often reflects views on the company's next blockbuster antibody candidates.

REGN DATA ON SQUAWKFLOW

Options Flow

Real-time REGN sweeps, blocks, and unusual options activity

Dark Pool Prints

Institutional REGN dark pool trades with size and sentiment

GEX Dashboard

REGN gamma exposure levels, call/put walls, and GEX flip

AI Narration

AI-powered analysis of REGN market microstructure in real time

News Sentiment

REGN news with AI sentiment scoring and impact analysis

Sector Context

Healthcare sector rotation and relative strength vs peers

Track REGN Live

Real-time options flow, GEX dashboard, dark pool alerts, and AI narration — free.

Open Terminal →

LEARN MORE

Implied Volatility Explained: What Every Trader Must Know

A thorough explanation of implied volatility, how it is calculated, what it means, and how to use it in trading.

Max Pain Theory in Options: How It Works and Whether to Trust It

Understanding the max pain theory, how to calculate it, its track record, and practical ways to use it in your trading.